← Back to headlines
Merck and Rivals Reportedly Interested in Inhibrx Cancer Drug
Pharmaceutical giant Merck and other rival companies are reportedly showing interest in acquiring Inhibrx's cancer drug, signaling potential major developments in the oncology market.
22 Apr, 12:37 — 22 Apr, 12:37
Sources
Showing 1 of 1 sources
